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A series of pyrazole derivatives 9-22 were designed and syn thesized. All the newly synthesized compounds were as sayed for their antimicrobial activity against the Grampositive bacteria Staphyllococcus aureus and Bacillius subtilis and the Gram-negative bacteria Escherichia coli, Pseudomonas aeruginosa, in addition to the fungi organisms, Candida albicans, C. parapsilosis and C. tropicalis. Ethyl 5-(2,5-dimethylthiophen-3-yl)-1-phenyl-1H-pyrazole-3-carboxylate (21) (MIC E.coli = 0.038 µmol mL ) is more active than fluconazole (0.020 µmol mL Keywords: pyrazole-3-carboxylates, antimicrobial activity Nitrogen heterocycles are of special interest because they constitute an important class of natural and non-natural products, many of which exhibit useful biological activities. Pyrazoles and their derivatives exhibit antimicrobial (1-3), anticancer (4), antiinflammatory (5) radioprotective (6) , anticonvulsant (7) and antimalarial (8) activities. In the light of these facts, and as a continuation of our efforts towards synthesizing biologically active heterocyclic compounds (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) , we aimed to prepare new derivatives of pyrazoles. The compounds were designed with the aim of exploring their antimicrobial activity and to study their structure-activity relationship.
EXPERIMENTAL
Melting points were uncorrected and determined on an electrothermal melting point apparatus (Stuart Scientific, UK). Precoated silica gel plates (Kieselgel 0.25 mm, 60G F254, Merck, Germany) were used for thin layer chromatography. Developing solvent system was composed of chloroform/methanol (8:2) and the spots were detected under UV. IR spectra (KBr discs) were recorded on a FT-IR spectrophotometer (Perkin Elmer, USA). NMR spectra were scanned on a NMR spectrophotometer (Bruker, Switzerland) operating at 500 MHz for 1 H-and 125.76 MHz for 13 C NMR. Chemical shifts are expressed in d-values (ppm) relative to TMS as an internal standard, using DMSO-d 6 as a solvent. Elemental analyses were done on a model 2400 CHNSO analyzer (Perkin Elmer, USA). All reagents were purchased from Sigma (USA). Compounds 1 and 9 were prepared according to the reported methods (19, 20) .
Synthesis of ethyl 4-(substituted phenyl)-2-hydroxy-4-oxobut-2-enoates (1-8)
Ethanol (100 mL) was converted to sodium ethoxide by portionwise addition of sodium (0.46 g, 0.02 mol) before a solution of diethyl oxalate (2.92 g, 0.02 mol) and acetophenone derivative, namely, 4-chloroacetophenone, 3,4-dimethoxyacetophenone, 2,5-dimethoxyacetophenone, 2,5-dichloroacetophenone, 2-chloro-4-bromoacetophenone, 1-(naphthalene-1-yl)ethanone, 1-(thiophen-2-yl)ethanone and/or 1-(2,5-dimethylthiophene-3-yl)ethanone (0.01 mol) in ethanol (50 mL) was added dropwise at 50 °C. The reaction mixture was heated under reflux for 2-3 h. After cooling the solvent was removed and the residue was taken up in water (200 mL) and acidified with concentrated HCl (1 mL). The aqueous mixture was extracted with diethyl ether (3x150 mL). The combined extracts were washed with brine (100 mL), dried (MgSO 4 ), and concentrated. The obtained solid was recrystallized from methanol to give compounds 1-8, respectively.
Synthesis of ethyl 1,5-disubstituted-1H-pyrazole-3-carboxylates (9-22)
A mixture of compound 1-8 (0.01 mol) with arylhydrazine derivative (0.012 mol) in ethanol (50 mL) was refluxed for 8 h. The reaction mixture was cooled and poured into ice water. The obtained solid was recrystallized from dioxane to give compounds 9-22, respectively.
Physico-chemical, analytical and spectral data are displayed in Tables I and II . Synthetic pathway is presented in Scheme 1.
Staphyloccocus aureus (NCTC-7447) and Bacillius subtilis (NCTC 1040) and Gram-negative bacteria E. coli (NCTC 10416), and Pseudomonas aeruginosa (ATCC 10145), in addition to the fungi organisms, Candida albicans (ATCC-10231), Candida parapsilosis (ATCC-22019) and Candida tropicalis (ATCC-66029) were tested. All microorganisms were purchased from American Type Culture Collection (Manassas, USA).
The antimicrobial activity screening of the newly synthesized compounds (9-22) was undertaken using the agar cup diffusion (8 mm diameter) assay I (21) . The agar media were inoculated with test organisms and a solution of test compound 100 µg mL -1 in DMSO. Ampicillin (100 and 50 µg mL ) were used as reference drugs for antibacterial and antifungal activity, respectively. The zones of inhibition were measured after 24 h of incubation.
For determination of minimum inhibitory concentration (MIC) (21) by serial plate dilution method, five milligrams of each test compounds were dissolved in 1 mL of dimethylsulfoxide (DMSO) separately to prepare stock solution. From stock solution serial dilutions were prepared. The plates were incubated at 37 °C for 24 h. MIC is the lowest concentration (µmol mL -1 ) of the test compound that resulted in no visible growth on the plates. DMSO was used as a solvent control to ensure that solvent had no effect on bacterial growth. The results of the antimicrobial activities are summarized in Table III . RESULTS 
AND DISCUSSION
Compd. Ar X   9  10  11  12  13  14  15  16  17  18  19  20  21 22 Table III lists ). From these results it was found that the presence of 2,5-dimethylthienyl moiety at 5-position and unsubsituted phenyl ring at 1-position in compound 21 enhanced the antibacterial activity against E. coli, while the presence of (un)substituted aromatic hydrocarbon moiety or unsubstituted thienyl at 5-position and (un)substituted phenyl ring at 1-position in compounds 9-20, 22 revealed a moderate or weak activity. Dihalogenated phenyl at 5-position and unsubstituted phenyl at 1-position in compound 16 revealed significant activity compared with fluconazole as reference drug against C. parapsilosis. The remaining compounds were found either weak or inactive. 
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CONCLUSIONS
This study showed that the newly synthesized ethyl 5-(2,5-dimethylthiophen-3-yl)-1-phenyl-1H-pyrazole-3-carboxylate (21) was found to be of comparable activity as ampicillin against E. coli and P. aeruginosa. The same is true for ethyl 5-(4-bromo-2-chlorophenyl)-1-phenyl-1H-pyrazole-3-carboxylate (16) vs. fluconazole against Candida parapsilosis. This is due to the presence of dihalogenated phenyl at 5-position and unsubstituted phenyl at 1-position of the pyrazole ring.
